What is the optimal duration for immunotherapy? Can intranasal steroids be combined with LRTAs? Test your allergy IQ.
An experimental cell-based therapy induces permanent allergen-specific immunologic tolerance to prevent IgE-mediated allergy.
Why has the number of food allergies increased but overall sensitization to food allergens remained static?
Spring has sprung! Click here for the latest research about some of the more common diseases of the season.
Results of a new study help explain why your adult patients with atopy most likely have autumn birthdays.
Poor agreement between caregiver and children for report of symptoms and relief presents a challenge in clinical trials.
The emerging therapy may help overcome drawbacks of existing immunotherapies, such as treatment duration and poor adherence.
Hay fever is common in adults age 65 years and older but there is little research on the efficacy of customary immunotherapy in this group.
The once-daily Oralair tablet may considerably change the experience of seasonal allergy sufferers.
Current and emerging treatment options for ragweed-induced rhinoconjunctivitis are the topic of a comprehensive review paper--a good read for all primary care providers.